Breakthrough therapy

Results: 60



#Item
11--------------------------------CONTRAINDICATIONS-----------------------------­ EPCLUSA and ribavirin combination regimen is contraindicated in patients for whom ribavirin is contraindicated (4) HIGHLIGHTS OF PRESCRIBIN

--------------------------------CONTRAINDICATIONS-----------------------------­ EPCLUSA and ribavirin combination regimen is contraindicated in patients for whom ribavirin is contraindicated (4) HIGHLIGHTS OF PRESCRIBIN

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2016-06-28 12:26:37
12GENERAL CONFORMITY CERTIFICATE Pursuant to 15 U.S.C. § 2063(a), Gilead Sciences, Inc. certifies that based on a reasonable testing program, the product referenced in this certificate complies with applicable regulations

GENERAL CONFORMITY CERTIFICATE Pursuant to 15 U.S.C. § 2063(a), Gilead Sciences, Inc. certifies that based on a reasonable testing program, the product referenced in this certificate complies with applicable regulations

Add to Reading List

Source URL: www.gilead.com

Language: English - Date: 2016-06-28 22:53:08
13Pharmaceuticals and Medical Devices Agency This English version is intended to be a reference material to provide convenience for users. In the event of inconsistency between the Japanese original and this English transl

Pharmaceuticals and Medical Devices Agency This English version is intended to be a reference material to provide convenience for users. In the event of inconsistency between the Japanese original and this English transl

Add to Reading List

Source URL: www.pmda.go.jp

Language: English - Date: 2016-08-04 23:25:54
14Treatment of Chronic Hepatitis C - January 2016 Update (The changes compared to the November 2015 Update are highlighted in yellow) Swiss Association for the Study of the Liver and Swiss Society for Infectious Diseases

Treatment of Chronic Hepatitis C - January 2016 Update (The changes compared to the November 2015 Update are highlighted in yellow) Swiss Association for the Study of the Liver and Swiss Society for Infectious Diseases

Add to Reading List

Source URL: sasl.unibas.ch

Language: English - Date: 2016-01-13 10:08:24
15Interim statement from the BCSH CLL Guidelines Panel George A Follows1, Adrian Bloor2, Claire Dearden3, Steve Devereux4, Christopher P Fox5, Peter Hillmen6, Ben Kennedy7, Helen McCarthy8, Nilima Parry-Jones9, Piers EM Pa

Interim statement from the BCSH CLL Guidelines Panel George A Follows1, Adrian Bloor2, Claire Dearden3, Steve Devereux4, Christopher P Fox5, Peter Hillmen6, Ben Kennedy7, Helen McCarthy8, Nilima Parry-Jones9, Piers EM Pa

Add to Reading List

Source URL: www.bcshguidelines.com

Language: English - Date: 2015-07-22 04:38:28
16Microsoft PowerPoint - Poster EASL 08 IDU MD.ppt

Microsoft PowerPoint - Poster EASL 08 IDU MD.ppt

Add to Reading List

Source URL: www.arud.ch

Language: English - Date: 2016-03-03 12:17:00
1712-AUG:10 Lung-MAP ACCRUAL REPORT 18:10 Friday, August 12, 2016 STUDY

12-AUG:10 Lung-MAP ACCRUAL REPORT 18:10 Friday, August 12, 2016 STUDY

Add to Reading List

Source URL: www.swogstat.org

Language: English - Date: 2016-08-19 21:10:16
18Guidelines EASL Recommendations on Treatment of Hepatitis C 2015 European Association for the Study of the Liver ⇑ Introduction

Guidelines EASL Recommendations on Treatment of Hepatitis C 2015 European Association for the Study of the Liver ⇑ Introduction

Add to Reading List

Source URL: www.easl.eu

Language: English - Date: 2015-09-08 13:26:17
19Pharmaceuticals and Medical Devices Agency This English version is intended to be a reference material for the convenience of users. In the event of inconsistency between the Japanese original and this English translatio

Pharmaceuticals and Medical Devices Agency This English version is intended to be a reference material for the convenience of users. In the event of inconsistency between the Japanese original and this English translatio

Add to Reading List

Source URL: www.pmda.go.jp

Language: English - Date: 2016-08-04 23:26:02
20This is an electronically controlled document. User is responsible to verify and use the current revision. GENERAL CONFORMITY CERTIFICATE Pursuant to 15 U.S.C. § 2063(a), Gilead Sciences, Inc. certifies that based on a

This is an electronically controlled document. User is responsible to verify and use the current revision. GENERAL CONFORMITY CERTIFICATE Pursuant to 15 U.S.C. § 2063(a), Gilead Sciences, Inc. certifies that based on a

Add to Reading List

Source URL: www.gilead.com

Language: English - Date: 2015-10-19 17:28:06